Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma

Table 1

Prognostic EMT genes of osteosarcoma in the TARGET cohort.

EMT genes	HR	HR.95L	HR.95H	value
ACTA2	0.60007	0.478306	0.752831	1.02E-05
CADM1	1.563352	1.03282	2.366404	0.034631
CALD1	0.687834	0.503844	0.939013	0.018464
CD59	0.578201	0.340429	0.982043	0.042661
CDH11	0.646305	0.426496	0.979399	0.039579
COL5A2	1.796028	1.21462	2.655742	0.003344
COL8A2	0.830052	0.695262	0.990972	0.039373
CXCL12	0.701203	0.527838	0.931508	0.014302
DAB2	0.552834	0.356892	0.856351	0.007943
DCN	0.687972	0.532825	0.888294	0.004125
DKK1	1.217418	1.017358	1.456819	0.031726
EDIL3	0.533263	0.387603	0.733661	0.000112
FAP	0.751864	0.601025	0.940557	0.012547
FAS	0.698216	0.49836	0.978218	0.0368
FBLN1	0.825041	0.688457	0.988721	0.037269
FUCA1	0.538319	0.351718	0.82392	0.004346
GADD45B	1.585384	1.089054	2.307914	0.016163
GLIPR1	0.596184	0.399629	0.889413	0.011271
GPX7	2.237357	1.229706	4.0707	0.008362
ID2	1.676029	1.016465	2.763573	0.042973
ITGB5	0.656243	0.465517	0.925111	0.016205
LGALS1	0.628315	0.437404	0.902552	0.01191
LOX	1.778616	1.212237	2.609618	0.003241
LOXL1	0.738146	0.595854	0.914418	0.005456
MAGEE1	0.505129	0.30388	0.839659	0.008439
MYL9	0.654679	0.468967	0.913933	0.012821
NID2	0.765564	0.595752	0.983779	0.036818
PCOLCE2	1.351295	1.050002	1.739042	0.019333
PMEPA1	0.618542	0.439716	0.870092	0.005794
POSTN	0.806768	0.651984	0.998298	0.048195
SERPINE2	1.647594	1.220342	2.224429	0.001114
SERPINH1	2.061795	1.199287	3.544606	0.008863
TAGLN	0.641922	0.464091	0.887895	0.007398
TNFRSF11B	1.470617	1.142542	1.892898	0.002748
TNFRSF12A	0.662569	0.470071	0.933897	0.018749
TPM1	0.505179	0.324643	0.786111	0.002473
TPM4	0.597236	0.374292	0.952974	0.030618
VCAM1	0.71391	0.55234	0.922742	0.010049
VEGFA	1.440634	1.123444	1.847379	0.00401
WNT5A	0.64968	0.452996	0.93176	0.019071